|
Congressional:
President Trump Signs the One Big Beautiful Bill Act into Law
Last week, on Friday, July 4, Trump signed the One Big Beautiful Bill Act (H.R.1) into law. Earlier last week, on Tuesday, the Senate passed the bill in a 51-50 vote, with Vice President Vance casting the tie-breaking vote. The House followed, passing the bill in a 218-214 vote on Thursday. The law extends most of the individual and estate provisions of Trump’s 2017 Tax Cuts and Jobs Act, which were largely set to expire at the end of 2025. The bill also enacts new tax benefits Trump promised during his 2024 election campaign, including exempting taxes on tips and overtime pay, though only through 2028. To offset the cost of the tax cuts, the legislation includes approximately $1 trillion in Medicaid cuts, through new Medicaid work requirements of 80 hours per month, increased Medicaid eligibility verification, and reduced state provider taxes, among other measures. Read Mehlman’s analysis of the key final provisions included in the One Big Beautiful Bill Act here.
Senate HELP Committee Advances Susan Monarez Nomination to be CDC Director
On Wednesday, the Senate Health, Education, Labor and Pensions (HELP) Committee held a markup on the nomination of Susan Monarez to lead the Centers for Disease Control and Prevention (CDC). The HELP Committee voted 12-11 to advance her nomination to the full Senate.
Senate HELP Committee Holds Hearing on Cybersecurity in Health Care
On Wednesday, the Senate Health, Education, Labor and Pensions (HELP) Committee held a full committee hearing on enhancing cybersecurity and protecting privacy in health care. During the hearing, Republicans, led by Chair Bill Cassidy (R-LA), emphasized the need to enhance cybersecurity in healthcare and protect sensitive health information. Members highlighted recent breaches and the need to modernize HIPAA, including the handling of data from wearables and apps. Ranking Member Bernie Sanders (I-VT) criticized the reconciliation bill for making significant Medicaid cuts, stating that it would result in millions losing health insurance and unnecessary deaths. Democrats also supported a comprehensive federal privacy law to protect health data, addressing concerns about the patchwork of state laws. Read Mehlman’s hearing summary here.
Representative Buddy Carter Announces Resignation as Chair of the Subcommittee on Health
Last week, on Wednesday, Representative Buddy Carter (R-GA) announced that he was stepping down as Chairman of the Energy and Commerce Committee’s Subcommittee on Health to focus on other priorities. On Thursday, Energy and Commerce Committee Chair Guthrie (R-KY) announced that Representative Morgan Griffith (R-VA) has been appointed Chairman of the Subcommittee on Health. Representative Diana Harshbarger (R-TN) will be the new Health Subcommittee vice chair, and Representative Neal Dunn (R-FL) will become vice chair of the full committee. Read Carter’s statement here and the E&C press release here.
Notable Bills Introduced:
Senators Scott, Warnock, and Colleagues Introduce Hospital at Home Healthcare Bill
On Thursday, Senators Tim Scott (R-SC) and Reverend Raphael Warnock (D-GA) introduced the Hospital Inpatient Services Modernization Act, legislation that would extend the Acute Hospital at Home Waiver program, which currently allows thousands of Americans to receive hospital-level care in their homes through a Center for Medicare and Medicaid Services (CMS) waiver. Read the press release here and the bill here.
Senators Luján, Boozman Reintroduce Legislation to Prevent Physical Therapy Interruptions
On Wednesday, Senators Ben Ray Luján (D-NM) and John Boozman (R-AR) reintroduced the Prevent Interruptions in Physical Therapy Act to prevent the interruption of physical therapy services nationwide. The legislation builds on previous legislation passed into law in the 21st Century Cures Act that enables physical therapists in rural, medically underserved, and health professional shortage areas to ensure their patients continue to receive quality care during a temporary absence. This bill would extend the same flexibility to all physical therapists and patients nationwide. Read the press release here and the bill here.
Representatives Gray, Murphy, Dunn Introduce Bipartisan Legislation to Protect Patient Access to Prescription Drugs
On Wednesday, Representatives Adam Gray (D-CA), Greg Murphy, MD (R-NC), and Neal Dunn (R-FL) introduced the bipartisan Protecting Patient Access to Cancer and Complex Therapies Act. The legislation would revise the existing physician reimbursement policy to ensure fair payment for health care providers and secure commercial access to prescription drugs for patients. Read the press release here and the bill here.
Executive Branch:
CMS Releases CY 2026 Home Health Prospective Payment System Proposed Rule
Last week, on Monday, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that proposes updates to Medicare payment policies and rates for home health agencies (HHAs) under the Home Health (HH) Prospective Payment System (PPS) Proposed Rule for calendar year (CY) 2026. The rule proposes a permanent 4.059% cut to the base rate to account for the shift to the patient-driven groupings model. In addition to the proposed permanent adjustment, CMS is also proposing to apply a -5.0% temporary adjustment on a prospective basis to the CY 2026 base payment rate, in accordance with statutory requirements to recoup retrospective overpayments. CMS expects to continue evaluating data for future temporary adjustments beyond 2026. Comments are due by September 2, 2025. Read the fact sheet here and the rule here.
CMS Releases Calendar Year (CY) 2026 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule
Last week, on Monday, CMS released the “End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model” (ESRD CY 2026 PPS or Proposed Rule). For CY 2026, CMS is proposing to increase the ESRD PPS base rate to $281.06, which CMS expects would increase total payments to all ESRD facilities, both freestanding and hospital-based, by approximately 1.9%. The CY 2026 ESRD PPS proposed rule also includes a proposed payment adjustment for certain non-labor costs for ESRD facilities located in Alaska, Hawaii, and the United States (U.S.) Pacific Territories. CMS is also proposing the early termination of the ESRD Treatment Choices Model. Comments are due August 29, 2025. Read the fact sheet here and the proposed rule here.
NIH Announces Cap on Excessive Publisher Fees for Publicly Funded Research
On Tuesday, the National Institutes of Health (NIH) announced plans to implement a new policy that will cap how much publishers can charge NIH-supported scientists to make their research findings publicly accessible. According to NIH, some major publishers charge upward of $13,000 per article for immediate open access. In response, the NIH will introduce a cap on allowable publication costs starting in Fiscal Year (FY) 2026, ensuring that publication fees remain reasonable across the research ecosystem. The policy aims to curb article processing charges and ensure the broad dissemination of research findings without unnecessary financial barriers. Read the press release here.
HHS Seeks Whistleblowers for DEI Examples in Grants, Workforce
On Monday, the Department of Health and Human Services (HHS) emailed staff a “whistle-blower questionnaire” asking staff to report cases of discrimination due to past diversity, equity, and inclusion (DEI) directives. The email asks staff five questions about whether they’ve witnessed people nix grants or contracts “with discriminatory language” and if they knew current and former staff passed over for promotions or hiring due to “race, religion, gender, national origin, age, disability or genetic information.” The survey also asked employees whether they knew former career employees who had quit or faced discipline during the Biden administration for refusing to execute DEI orders, and whether people could identify DEI policies that “caused discrimination against employees, contractors or members of the general public.”
Legal & Other:
Supreme Court Allows Trump’s Order for Reduction in Force Across Federal Government
On Tuesday, the Supreme Court granted an emergency appeal from the administration seeking permission to enforce a February 11 executive order that instructed agencies to carry out large-scale reductions in force (RIF). In an unsigned decision, the Supreme Court lifted an injunction issued by U.S. District Judge Susan Illston, who had blocked 21 agencies from complying with the mass RIF. The decision stated that it was not assessing the legality of any particular agency’s layoff plans or any moves taken so far to implement those plans. Justice Ketanji Brown Jackson was the sole member of the court to record a dissent. Read the decision here.
Judge Temporarily Blocks Budget Law's Planned Parenthood Defunding
On Monday, a federal judge on Monday issued a temporary restraining order blocking a provision in Republicans' budget reconciliation law that imposes a one-year ban on state Medicaid payments to health care nonprofits that also offer abortions and received more than $800,000 in federal funding in 2023. U.S. District Judge Indira Talwani issued the order, which will remain in effect for 14 days unless the court makes changes. The decision came hours after Planned Parenthood filed the lawsuit in federal court in Massachusetts, challenging the provision.
Supreme Court Declines Case on Regulating Pharmacy Benefit Managers
On Monday, July 1, the Supreme Court declined to consider an appellate court’s 2023 decision overturning portions of an Oklahoma law regulating pharmacy benefit managers (PBMs). The 10th Circuit appeals court ruled that federal laws regulating private employer-sponsored health plans and Medicare’s drug benefit preempt the 2019 state law’s provisions that aimed to bolster independent pharmacies’ bargaining power with PBMs. Nearly three dozen states and Washington, D.C., plus several pharmacy organizations, joined the case as “friends of the court” on the side of Oklahoma.
|